Scientific & Patient Advisory Board
Scientific & Patient Advisory Board
We have assembled a group of world-leading clinicians and dedicated patient advocates who generously provide us with expert insights and guidance as we work to develop new treatments for inflammatory conditions of the eye.
Dr. George Kahaly
Johannes Gutenberg University Medical Center
Dr. Andrea Kossler
Stanford University School of Medicine
Dr. Prem Subramanian
University of Colorado School of Medicine
Dr. Shoaib Ugradar
Department of Orbital and Oculoplastic Surgery, Beverly Hills, California
Christine Gustafson
Executive Director and CEO of the TED Community Organization
Latest Press Releases
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
Press Release
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
Read more ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
Press Release
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
Read more 